Gene Therapy Stalls Development Of Huntington's Disease In Mice, California Institute of Technology Study
Caltech -- Pasadena, Calif.—Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.